Cancer cell killing using engineered intracellular antibody fragments
<p>Cancer is one of the leading causes of morbidity and death worldwide, with many either refractory to current therapy regimens or subsequently developing resistance. Novel targeted therapies are therefore needed. Acute T cell leukaemia (T-ALL) is an example of a malignancy without targete...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
2018
|